Congenital dyserythropoietic anemia type II in a newborn with a novel compound heterozygous mutation in the SEC23B: a case report and review of the literature

Iolascon A, Heimpel H, Wahlin A, Tamary H. Congenital dyserythropoietic anemias: molecular insights and diagnostic approach. Blood. 2013;122:2162–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gambale A, Iolascon A, Andolfo I, Russo R. Diagnosis and management of congenital dyserythropoietic anemias. Expert Rev Hematol. 2016;9:283–96.

Article  CAS  PubMed  Google Scholar 

Bianchi P, Fermo E, Vercellati C, Boschetti C, Barcellini W, Iurlo A, et al. Congenital dyserythropoietic anemia type II (CDAII) is caused by mutations in the SEC23B gene. Hum Mutat. 2009;30:1292–8.

Article  CAS  PubMed  Google Scholar 

Schwarz K, Iolascon A, Verissimo F, Trede NS, Horsley W, Chen W, et al. Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II. Nat Genet. 2009;41:936–40.

Article  CAS  PubMed  Google Scholar 

Heimpel H, Anselstetter V, Chrobak L, Denecke J, Einsiedler B, Gallmeier K, et al. Congenital dyserythropoietic anemia type II: epidemiology, clinical appearance, and prognosis based on long-term observation. Blood. 2003;102:4576–81.

Article  CAS  PubMed  Google Scholar 

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foste J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med. 2015;17:405–24.

Article  PubMed  PubMed Central  Google Scholar 

Bianchi P, Schwarz K, Hogel J, Fermo E, Vercellati C, Grosse R, et al. Analysis of a cohort of 101 CDAII patients: description of 24 new molecular variants and genotype-phenotype correlations. Br J Haematol. 2016;175:696–704.

Article  CAS  PubMed  Google Scholar 

Russo R, Gambale A, Langella C, Andolfo I, Unal S, Iolascon A. Retrospective cohort study of 205 cases with congenital dyserythropoietic anemia type II: definition of clinical and molecular spectrum and identification of new diagnostic scores. Am J Hematol. 2014;89:E169–75.

Article  PubMed  Google Scholar 

Musri MM, Venturi V, Ferrer-Cortès X, Romero-Cortadellas L, Hernández G, Leoz P, et al. New cases and mutations in SEC23B gene causing congenital dyserythropoietic anemia type II. Int J Mol Sci. 2023;24(12):9935.

Article  PubMed  PubMed Central  Google Scholar 

Moreno-Carralero MI, Horta-Herrera S, Morado-Arias M, Ricard-Andrés MP, Lemes-Castellano A, Abio-Calvete M, et al. Clinical and genetic features of con-genital dyserythropoietic anemia (CDA). Eur J Haematol. 2018;101(3):368–78.

Article  CAS  PubMed  Google Scholar 

Iolascon A, Andolfo I, Russo R. Congenital dyserythropoietic anemias. Blood. 2020;136(11):1274–83.

Article  PubMed  Google Scholar 

Iolascon A, Andolfo I, Barcellini W, Corcione F, Garçon L, De Franceschi L, Working Study Group on red cells and iron of the EHA, et al. Recommendations regarding splenectomy in hereditary hemolytic anemias. Haematologica. 2017;102(8):1304–13.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Uygun V, Russo R, Karasu G, Daloğlu H, Iolascon A, Yeşilipek A. Hematopoietic stem cell transplantation in congenital dyserythropoetic anemia type II: a case report and review of the literature. J Pediatr Hematol Oncol. 2020;42(6):e507–10.

Article  PubMed  Google Scholar 

留言 (0)

沒有登入
gif